The pharmaceutical company Delpharm has appointed Alain Kirchmeyer to the position of managing director.
 
With 30 years of experience in B2B markets, including 20 years based outside France, Alain was previously managing director for the French manufacturer Unither Pharmaceuticals. He will oversee the group’s management with the objective of enabling Delpharm to accelerate its performance in Europe and North America. He will report to Sebastien Aguettant who remains president of Delpharm.
 
Kirchmeyer is a civil engineer at the École des Mines and speaks fluent French, English and Chinese. Prior to joining Unither Pharmaceuticals in 2019, Alain held operational and general management positions at Johnson Matthey PLC, Morgan Advanced Materials PLC or Saint-Gobain.
 
“We are delighted with the arrival of Alain Kirchmeyer whose experience in positions of responsibility and in the General Directorates of major groups will be invaluable to us. His expertise and network will also allow Delpharm to accelerate its internationalization, with an installed base of 6 plants outside France,” commented Sebastien Aguettant.